enow.com Web Search

  1. Ads

    related to: eye prism correction device for macular degeneration

Search results

    15.47+0.38 (+2.52%)

    at Mon, Jun 3, 2024, 4:00PM EDT - U.S. markets closed

    Nasdaq Real Time Price

    • Open 15.00
    • High 15.72
    • Low 15.00
    • Prev. Close 15.09
    • 52 Wk. High 27.02
    • 52 Wk. Low 13.71
    • P/E N/A
    • Mkt. Cap 1.22B
  1. Results from the WOW.Com Content Network
  2. Retinal implant - Wikipedia

    en.wikipedia.org/wiki/Retinal_implant

    A retinal implant is a visual prosthesis for restoration of sight to patients blinded by retinal degeneration. The system is meant to partially restore useful vision to those who have lost their photoreceptors due to retinal diseases such as retinitis pigmentosa (RP) or age-related macular degeneration (AMD).

  3. How to reduce risks of macular degeneration - AOL

    www.aol.com/lifestyle/actress-judi-dench-says...

    Macular degeneration happens with age, when the macula, at the center of the retina — “the part of the eye that sees the world for us,” Dr. Vlad Diaconita, a retinal and vitreoretinal ...

  4. Macular degeneration - Wikipedia

    en.wikipedia.org/wiki/Macular_degeneration

    8.7% global prevalence in 2020 [2] Macular degeneration, also known as age-related macular degeneration ( AMD or ARMD ), is a medical condition which may result in blurred or no vision in the center of the visual field. [1] Early on there are often no symptoms. [1] Over time, however, some people experience a gradual worsening of vision that ...

  5. Visual prosthesis - Wikipedia

    en.wikipedia.org/wiki/Visual_prosthesis

    A visual prosthesis, often referred to as a bionic eye, is an experimental visual device intended to restore functional vision in those with partial or total blindness. Many devices have been developed, usually modeled on the cochlear implant or bionic ear devices, a type of neural prosthesis in use since the mid-1980s.

  6. Merck to buy eye-focused drug developer EyeBio for as ... - AOL

    www.aol.com/news/merck-acquire-eye-drug-company...

    (Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion, as it looks to diversify its portfolio of experimental drugs with treatments for eye diseases.

  7. Vitelliform macular dystrophy - Wikipedia

    en.wikipedia.org/wiki/Vitelliform_macular_dystrophy

    Specialty. Ophthalmology, medical genetics. Vitelliform macular dystrophy is an irregular autosomal dominant eye disorder which can cause progressive vision loss. [1] This disorder affects the retina, specifically cells in a small area near the center of the retina called the macula.

  1. Ad

    related to: eye prism correction device for macular degeneration